|Year : 2013 | Volume
| Issue : 1 | Page : 60-64
Metabolic syndrome among substance dependent men: A study from north India
Surendra Kumar Mattoo1, Naresh Nebhinani2, Munish Aggarwal1, Debasish Basu1, Parmanand Kulhara1
1 Department of Psychiatry, Post Graduate Institute of Medical Education and Research, Chandigarh, India
2 All India Institute of Medical Science, Jodhpur, Rajasthan, India
|Date of Web Publication||24-Dec-2013|
Department of Psychiatry, All India Institute of Medical Science, Jodhpur, Rajasthan 342 005
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Background: Substance abuse, alcohol in particular, is associated with increased risk of diabetes and metabolic syndrome (MS). The relationship between the substance abuse and MS is complex and the literature is sparse. Objectives: The present research was aimed to study the prevalence and predictors of MS among outpatients with substance dependence. Materials and Methods: Patients with substance dependence were recruited from a deaddiction center in North India, who attended outpatient clinic from 1 st January, 2010-31 st December, 2010. MS was assessed using International Diabetes Federation (IDF) criteria. Results: Out of 250 subjects, 34 (13.6%) of the subjects met the IDF criteria for MS and highest being in alcohol group (21.6%). The commonest abnormality was increased triglycerides (TG; 54%) and increased waist circumference (36.8%). Age, body weight, body mass index, and obesity were significant predictor of MS. Conclusion: MS was highest in subjects with alcohol dependence with the commonest abnormality of TG and blood pressure. Hence, routine screening is advisable in this population to address emerging MS.
Keywords: Alcohol, metabolic syndrome, opioid, substance dependence
|How to cite this article:|
Mattoo SK, Nebhinani N, Aggarwal M, Basu D, Kulhara P. Metabolic syndrome among substance dependent men: A study from north India. Ind Psychiatry J 2013;22:60-4
Substance abuse is associated with increased mortality,  one of the prominent causes being metabolic diseases.  Alcohol and tobacco use, in particular, have been associated with increased risk of diabetes,  cardiovascular mortality,  and the development of metabolic syndrome (MS); , which in turn is an important risk factor for cardiovascular diseases and all cause mortality.  MS is a cluster of abnormalities that include insulin resistance, hypertension, dyslipidemia, and abdominal obesity. Insulin resistance and a proinflammatory state have been hypothesized to result in the development of MS. ,
Subjects with substance use have increased risk of MS because of the nutritional deficiencies, increasing cell damage, augmenting excitotoxicity, reducing energy production, lowering the antioxidant potential of the cells, etc.  Though their relationship remains complex as low to moderate alcohol use has been found to lower the risk for MS, ,,,,,, while heavy alcohol use has been found to increase the risk for MS. ,,,, Some studies have reported increased MS even with low alcohol use. ,
The prevalence of MS in substance dependent population have been reported in the range of 5-31%. ,,,,,,,, Higher body mass index is also reported to contribute MS.  Research from India on MS and substance abuse is limited to only one study from North India.  The present research was aimed to study the prevalence and predictors of MS among inpatients with substance dependence.
| Materials and Methods|| |
The study was conducted at the Drug Deaddiction and Treatment Center (DDTC), Department of Psychiatry, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh - a multispecialty tertiary-care teaching hospital providing services to a major area of North India. The study had the approval of the institutional research ethics committee. Patients with any substance dependence were recruited from outpatient setting at their first contact at DDTC from 1 st January, 2010-31 st December, 2010. A cross-sectional design was employed and written informed consent was obtained from the patients taken up for the study. Diagnoses were made by consultant psychiatrist as per International Classification of Diseases - Classification of Mental and Behavioral Disorders - Clinical Descriptions and Diagnostic Guidelines tenth revision (ICD-10).  All of our patients were males as because of lack of separate facilities in this center, we admitted female substance users in psychiatric inpatient unit under the same department. After enrolment into the study, a semistructured proforma was used to assess demographic and substance use details.
Metabolic and anthropometric assessments
Body weight was measured in kilogram (kg) and height in centimeters (cm) by a calibrated scale. Waist circumference, in centimeters (cm), was measured midway between the inferior costal margin and the superior border of the iliac crest, at the end of normal expiration in standing position. At least two readings at 5 min intervals were recorded for blood pressure (BP) using standard mercury manometer in supine position. If blood pressure was found to be high (≥140/90) then a third reading was taken after 30 min; the lowest of these readings was taken. Fasting venous blood sample was collected under aseptic condition to measure the blood glucose (FBS), triglycerides (TG), and high density lipoprotein (HDL) levels.
MS was diagnosed using International Diabetes Federation (IDF) criteria.  According to IDF criteria a person is considered to have MS if he has high waist circumference (≥80 cm for females and ≥90 cm for males of Asian origin) along with two of the following criteria: Systolic blood pressure ≥130 mmHg and/or diastolic blood pressure ≥85 mmHg (or on treatment for hypertension), TG levels ≥150 mg/dl (or on specific treatment for this abnormality), HDL cholesterol <40 mg/dl for male and <50 mg/dl for females (or on specific treatment for this abnormality), FBS ≥100 mg/dl (or on treatment for diabetes mellitus). 
All patients and healthy controls with metabolic abnormalities were informed and educated about the need for proper diet and regular exercise, and referred for specialist care whenever required.
Analysis was done using the Statistical Package for Social Sciences (SPSS) version 14.0 for Windows (Chicago, Illinois, USA). Frequencies with percentages were calculated for categorical variables and mean and standard deviation (SD) were calculated for continuous variables. Chi-square test and t-test and one-way analysis of variance (ANOVA) were used for comparisons. Binary logistic regression was performed to examine the influence of independent variables on MS.
| Results|| |
A total of 250 subjects, all men, were included in the study. By the substance of dependence the groups were made: Alcohol (N = 97), opioid (N = 52), alcohol + opioid (N = 49), and other substance, with or without alcohol or opioid (others) (N = 52). Among the groups; 68, 73.1, 87.8, and 80.8 subjects respectively were currently using tobacco in dependent or nondependent pattern.
A typical study subject was aged 34.5 ± 1.04 years, married (68.8%), working (66.8%), from urban area (60%), Hindu (54.4%), educated up to matriculation (49.6%), and from nuclear family (47.2%). Compared to others, alcohol group was more often married, currently employed (P < 0.001) and older (P < 0.01), alcohol and others groups were more often Hindu (P < 0.001), and others group was more often from urban areas (P < 0.05). Majority of the subjects were from urban background in all the groups except in the alcohol + opioid group, who were from rural background [Table 1].
Mean duration of dependence was 7.16 years. MS criteria were met in 13.6% of the subjects and highest in alcohol group (21.6%) and the lowest in others group subjects (7.7%). Among the metabolic abnormalities, the commonest were increased TG (54%) and waist circumference (36.8%), and the least common were increased FBS level (6.4%) and low HDL (7.6%). Groups differed for hypertension by systolic or diastolic criteria (P < 0.001), high systolic and diastolic blood pressures (P < 0.01), duration of dependence and number of subjects with increased waist circumference (P < 0.01), and the prevalence of MS (P < 0.05). The groups were similar for the number of subjects with low HDL levels, high TG levels or high FBS. Nearly two-third of the subjects (62.8%) in entire sample was fulfilling one or two MS components [Table 2].
|Table 2: Clinical profile of total sample and substance dependent groups|
Click here to view
Comorbid psychiatric diagnosis present in 9.6% cases (N = 24), included depression (N = 6), and psychotic illness and bipolar affective disorder (BPAD; N = 5 each). Comorbid physical diagnosis were present in 14% (N = 35), included seizure disorder (N = 12) and diabetes mellitus and alcoholic liver disease (N = 5 each), while 13 subjects have other physical diagnosis.
Compared to those without MS, the subjects with MS were more often currently working (82.4 vs 55.1%; P < 0.01), married (85.3 vs 66.2%; P < 0.05), and older (38.2 vs 33.9 years; P < 0.05); and had higher body weight (79 vs 72 kg; P < 0.005), body mass index (27.7 vs 21.6; P < 0.01), and obesity (BMI ≥ 25) (76.5 vs 18.5%; P < 0.01).
Predictors of metabolic syndrome
Simple binary logistic regression analysis with enter method was used to study the relationship among independent variables which were more frequently present in subjects with MS in entire sample and individual groups. As shown in [Table 3], significant predictors of MS were greater age, higher body weight, higher body mass index and obesity (body mass index ≥ 25) in entire group. Of all predictors, odds ratio was highest (OR = 14.3) for obesity. In individual groups, significant MS predictors were body weight, BMI and obesity in alcohol group; BMI and obesity in opioid and others groups.
| Discussion|| |
Our typical study subject was a married, working, male in forth decade from urban area with 7.16 years of substance dependence. The demographic profile of our sample was similar to that of our clinic population. , Study consisted of all male subjects as more than 99% of the subjects that present to us for treatment are males. 
The prevalence rate of MS at 13.6% in the present study was within the range of 5-31% reported for subjects taking alcohol by the Western studies. ,,,,,,,, In our study, the prevalence of MS was found to be highest in the alcohol dependent group and it was also in the range of MS reported earlier. ,,,,,,,, Compared to the previous study from our center which was conducted in inpatient setting,  our study is from outpatient setting with bigger sample size (250 vs 100); MS rate is similar in alcohol group (21.6 vs 24.6%), but lower in opioid group (9.6 vs 29.3%). Our finding is also consistent with the reported increase in TG and decrease in HDL with heroin use by a study from the West. 
The most common abnormality in the present study being increased TG (54%) was similar to previous studies. , The significant difference among various groups for the number of subjects with increased waist circumference, hypertension, and prevalence of MS; signifies that the substance dependent population is a heterogeneous one and needs to be studied separately.
The subjects with MS being older and more likely to be married and employed in the present study, was a finding similar to that from other studies from our center in subjects with substance dependence.  Our subjects with MS was older and had more weight, higher BMI, and obesity; compared to subjects without MS and similar variables remained significant predictors of MS. Other studies ,, also reported age and body mass index as significant predictors of MS. These facts point to the need for physical examination and measurement of weight, waist circumference, and body mass index to be an essential part of the assessment of patients seeking deaddiction, especially for those aged >30 years.
This study had certain limitations. Being a hospital based sample, it was not a true representation of the community. A male only sample puts a restriction on the generalization of the findings. The lack of a matched control group further limits the conclusions on causal links.
To conclude, MS is prevalent amongst substance dependent subjects. Besides presence of MS, a significant proportion of patients had one or two metabolic abnormality. This suggests that clinicians should not just focus on patients who have MS, but also look at this high risk population, which can convert to MS positive cases. Hence, any patient who fulfills a single criterion of MS should be considered at risk for development of MS and the preventive strategies should be in place. Older age, higher body weight, and higher body mass index are certain risk factors for development of MS. However, these findings need further validation with larger samples, prospective, and longitudinal designs.
| References|| |
|1.||Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Actual causes of death in the United States, 2000. JAMA 2004;291:1238-45. |
|2.||Hansen AB, Lohse N, Gerstoft J, Kronborg G, Laursen A, Pedersen C, et al. Cause-specific excess mortality in siblings of patients co-infected with HIV and hepatitis C virus. PLoS One 2007;2:e738. |
|3.||Baik I, Shin C. Prospective study of alcohol consumption and metabolic syndrome. Am J Clin Nutr 2008;87:1455-63. |
|4.||Athyros VG, Liberopoulos EN, Mikhailidis DP, Papageorgiou AA, Ganotakis ES, Tziomalos K, et al. Association of drinking pattern and alcohol beverage type with the prevalence of metabolic syndrome, diabetes, coronary heart disease, stroke, and peripheral arterial disease in a Mediterranean cohort. Angiology 2008;58:689-97. |
|5.||Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001;24:683-9. |
|6.||Reaven GM. Role of insulin resistance in human disease (syndrome X): An expanded definition. Annu Rev Med 1993;44:121-31. |
|7.||Shoelson SE, Herrero L, Naaz A. Obesity, inflammation, and insulin resistance. Gastroenterology 2007;132:2169-80. |
|8.||Virmani A, Binienda ZK, Ali SF, Gaetani F. Metabolic syndrome in drug abuse. Ann N Y Acad Sci 2007;1122:50-68. |
|9.||Carnethon MR, Loria CM, Hill JO, Sidney S, Savage PJ, Liu K, Coronary Artery Risk Development in Young Adults study. Risk factors for the metabolic syndrome: The Coronary Artery Risk Development in Young Adults (CARDIA) study, 1985-2001. Diabetes Care 2004;27:2707-15. |
|10.||Djousse L, Arnett DK, Eckfeldt JH, Province MA, Singer MR, Ellison RC. Alcohol consumption and metabolic syndrome: Does the type of beverage matter? Obes Res 2004;12:1375-85. |
|11.||Freiberg MS, Cabral HJ, Heeren TC, Vasan RS, Curtis ER, Third National Health and Nutrition Examination Survey. Alcohol consumption and the prevalence of the Metabolic Syndrome in the US: A cross-sectional analysis of data from the Third National Health and Nutrition Examination Survey. Diabetes Care 2004;27:2954-9. |
|12.||Gigleux I, Gagnon J, St-Pierre A, Cantin B, Dagenais GR, Meyer F, et al. Moderate alcohol consumption is more cardioprotective in men with the metabolic syndrome. J Nutr 2006;136:3027-32. |
|13.||Lidfeldt J, Nyberg P, Nerbrand C, Samsioe G, Schersten B, Agardh CD. Socio-demographic and psychosocial factors are associated with features of the metabolic syndrome. The Women's Health in the Lund Area (WHILA) study. Diabetes Obes Metab 2003;5:106-12. |
|14.||Yoon YS, Oh SW, Baik HW, Park HS, Kim WY. Alcohol consumption and the metabolic syndrome in Korean adults: The 1998 Korean National Health and Nutrition Examination Survey. Am J Clin Nutr 2004;80:217-24. |
|15.||Fan AZ, Russell M, Dorn J, Freudenheim JL, Nochajski T, Hovey K, et al. Lifetime alcohol drinking pattern is related to the prevalence of metabolic syndrome. The Western New York Health Study (WNYHS). Eur J Epidemiol 2006;21:129-38. |
|16.||Urashima M, Takashi W, Tsutomu F, Joki M, Maeda T, Hashimoto H, et al. Prevalence of metabolic syndrome in a 22,892 Japanese population and its association with life style. Japan Med Assoc J 2005;49:441-50. |
|17.||Wilsgaard T, Jacobsen BK. Lifestyle factors and incident metabolic syndrome. The Tromso Study 1979-2001. Diabetes Res Clin Pract 2007;78:217-24. |
|18.||Zhu S, St-Onge MP, Heshka S, Heymsﬁeld SB. Lifestyle behaviors associated with lower risk of having the metabolic syndrome. Metabolism 2004;53:1503-11. |
|19.||Rosell M, Faire UD, Hellenius M. Low prevalence of the metabolic syndrome in wine drinkers- is it the alcohol beverage or the lifestyle? Eur J Clin Nutr 2003;57:227-34. |
|20.||Santos AC, Ebrahim S, Barros H. Alcohol intake, smoking, sleeping hours, physical activity and the metabolic syndrome. Prev Med 2007;44:328-34. |
|21.||Teixeira PJR, Rocha FL. The prevalence of metabolic syndrome among psychiatric inpatients in Brazil. Rev Bras Psiquiatr 2007;29:330-6. |
|22.||Villegas R, Creagh D, Hinchion R, O'Halloran D, Perry IJ. Prevalence and lifestyle determinants of the metabolic syndrome. Ir Med J 2004;97:300-3. |
|23.||Kanjilal S, Shanker J, Rao VS, Khadrinarasimhaih NB, Mukherjee M, Iyengar SS, et al. Prevalence and component analysis of metabolic syndrome: An Indian atherosclerosis research study perspective. Vasc Health Risk Manag 2008;4:189-97. |
|24.||Mattoo SK, Chakraborty K, Basu D, Ghosh A, Vijaya KK, Kulhara P. Prevalence and correlates of metabolic syndrome in alcohol and opioid dependent inpatients. Indian J Med Res 2011;134:341-8. |
|25.||World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders-Clinical Descriptions and Diagnostic Guidelines. WHO, Geneva; 1992. |
|26.||Alberti KG, Zimmet P, Shaw J. Metabolic syndrome - a new worldwide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2005;23:469-80. |
|27.||Basu D, Aggarwal M, Das PP, Mattoo SK, Kulhara P, Varma VK. Changing pattern of substance abuse in patients attending a de-addiction centre in North India (1978-2008). Indian J Med Res 2012;135:830-6. |
|28.||Pereska ZJ, Bozinovska C, Dimitrovski C, Petkovska L, Cibisev A, Jurukov I. Plasma apo/lipoproteins disturbances as a precondition for metabolic syndrome in HCV seronegative heroin addicts. Am J Drug Alcohol Abuse 2011;37:196-202. |
|29.||Kato I, Kiyohara Y, Kubo M, Tanizaki Y, Arima H, Iwamoto H, et al. Insulin-mediated effects of alcohol intake on serum lipid levels in a general population: The Hisayama Study. J Clin Epidemiol 2003;56:196-204. |
|30.||Deepa M, Farooq S, Datta M, Deepa R, Mohan V. Prevalence of metabolic syndrome using WHO, ATPIII and IDF definitions in Asian Indians: The Chennai Urban Rural Epidemiology Study (CURES-34). Diabetes Metab Res Rev 2007;23:127-34. |
|31.||Grover S, Nebhinani N, Chakrabarti S, Avasthi A, Kulhara P. Metabolic syndrome among patients receiving clozapine: A preliminary estimate. Indian J Pharmacol 2011;43:591-5. |
[Table 1], [Table 2], [Table 3]
|This article has been cited by|
||The Prevalence of Metabolic Syndrome in Alcohol Use Disorders: A Systematic Review and Meta-analysis
| ||Davy Vancampfort,Mats Hallgren,James Mugisha,Marc De Hert,Michel Probst,Dirk Monsieur,Brendon Stubbs |
| ||Alcohol and Alcoholism. 2016; |
|[Pubmed] | [DOI]|
||Metabolic syndrome in drug naïve patients with substance use disorder
| ||Manish Bathla,Manpreet Singh,Shazia Anjum,Parmanand Kulhara,Satyarth Jangli |
| ||Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2016; |
|[Pubmed] | [DOI]|
||The metabolic syndrome in patients with alcohol dependency: Current research and clinical implications
| ||Kai G. Kahl,Thomas Hillemacher |
| ||Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2016; 70: 49 |
|[Pubmed] | [DOI]|